Products

AusculThing ACC
AusculThing Oy
Cardiology AI
AusculThing ACC is an FDA-cleared AI-powered mobile application that records, displays, and analyzes heart sounds using an electronic stethoscope to aid healthcare providers in detecting and evaluating heart murmurs in adult and pediatric patients.

See all 1 product →

About AusculThing Oy

AusculThing Oy is a healthcare AI company focused on redefining cardiopulmonary healthcare through cutting-edge digital solutions. Their flagship product, the AusculThing ACC Software, is an FDA-cleared decision-support tool designed for healthcare professionals. It utilizes an AI-based algorithm to record, display, and analyze heart sounds, aiding in the accurate and efficient interpretation and evaluation of heart sounds in both adult and pediatric patients. The software boasts an advanced murmur detection feature, capable of identifying heart murmurs of any intensity and categorizing heart sounds as abnormal or normal based on the presence or absence of murmurs.

Physicians can leverage the AusculThing ACC Software to improve diagnostic accuracy with detailed heart sound recordings and analyses. The software is intended to be used in conjunction with a physician’s expertise and other relevant patient data, providing a complementary approach to traditional diagnostic methods for a more comprehensive understanding of a patient’s cardiac health. It is designed as a mobile application and is intended for use with an electronic stethoscope, such as the Thinklabs One, facilitating both acoustic and visual playback of heart sounds for detailed examinations and educational purposes. The company also offers “AusculThing Learn,” an interactive platform for medical students and healthcare professionals to study and practice identifying various heart defects using visual and audio cues.

Focus Areas

cardiopulmonary healthcare AI-powered diagnostics digital auscultation medical education heart sound analysis

Business Intelligence

Technologycloud-native (implied by software delivery and app availability), AI operating system (for heart sound analysis)

What Physicians Need to Know

Cardiopulmonary Healthcare & Digital Auscultation
AusculThing Oy specializes in redefining cardiopulmonary healthcare through cutting-edge digital solutions. Their AusculThing ACC software, an FDA-cleared mobile app, uses an electronic stethoscope (specifically the Thinklabs One) to record, display, and analyze heart sounds in both adult and pediatric patients. This digital approach aims to make cardiac care more precise, affordable, and adaptable, extending from homes to specialized care settings. The software provides both acoustic and visual playback of heart sounds, aiding in detailed examinations.
AI-Powered Diagnostics & Heart Sound Analysis
At the core of AusculThing's offerings is its AI-based algorithm, trained on a proprietary database of high-quality echocardiogram data. This algorithm enables advanced murmur detection, identifying heart murmurs of any intensity and categorizing heart sounds as normal or abnormal. This capability helps healthcare providers quickly identify potential cardiac issues. The software boasts impressive performance metrics: 93% accuracy, 91% sensitivity, and 96% specificity in detecting heart murmurs.
Medical Education
AusculThing Learn is an interactive platform designed for medical students and healthcare professionals to explore and understand various heart defects using immersive visual and audio cues. It offers a unique opportunity to delve into cardiac abnormalities through visual representations and audio samples, providing a comprehensive understanding of different heart defects and their associated sounds. The platform also includes a practice section with quizzes featuring diverse audio and visual samples to sharpen diagnostic abilities.
Key Differentiators
AusculThing's key differentiators include its FDA-cleared AI-powered software for heart sound analysis, its high accuracy, sensitivity, and specificity in murmur detection (93%, 91%, 96% respectively), and its focus on providing a decision-support tool that complements a physician's expertise rather than replacing it. The mobile app format enhances accessibility and user-friendliness, allowing for easy recording and playback of heart sounds. Their research extends to expanding algorithms for detecting new heart conditions.
Technology Stack
The AusculThing ACC software runs as a mobile application and is designed to be used with an electronic stethoscope, specifically the Thinklabs One. The core of their diagnostic capability is an AI-based algorithm, trained on a proprietary database of echocardiogram data. While specific programming languages or cloud platforms are not explicitly detailed, the emphasis is on AI/machine learning for sound analysis and digital signal processing.
Physician Tip

For physicians, AusculThing ACC acts as a powerful decision-support tool, enhancing the accuracy and efficiency of heart sound interpretation. It is crucial to remember that the software is not a standalone diagnostic device; its analysis is most effective when combined with your clinical expertise and other patient data. The visual and acoustic playback features can be particularly useful for detailed examinations, patient education, and even for training purposes. The high accuracy, sensitivity, and specificity in murmur detection can aid in early identification of potential cardiac issues, especially in both adult and pediatric populations. Additionally, the AusculThing Learn platform offers a valuable resource for continuous medical education and skill refinement in cardiac auscultation.

AusculThing ACC is designed to integrate with the Thinklabs One electronic stethoscope for optimal performance. While the current information focuses on this specific hardware integration, the nature of digital auscultation and AI-powered analysis suggests potential for future integrations with electronic health records (EHRs) for streamlined patient data management and telemedicine platforms for remote consultations, though these are not explicitly stated as current features.

Products by AusculThing Oy

1 product in the directory

AusculThing ACC
AusculThing Oy
Cardiology AI
AusculThing ACC is an FDA-cleared AI-powered mobile application that records, displays, and analyzes heart sounds using an electronic stethoscope to aid healthcare providers in detecting and evaluating heart murmurs in adult and pediatric patients.

What the Web Says

AusculThing Oy is a Finnish company that develops digital solutions for cardiopulmonary healthcare, with a focus on heart sound analysis. Their primary product, AusculThing ACC software, is an FDA-cleared decision-support tool that uses AI-based algorithms to help healthcare providers interpret heart sounds. They also offer the AusculThing Learn app, designed for medical professionals to improve their auscultation skills.

Overall: Positive

Strengths

  • AusculThing ACC software provides detailed heart sound recordings and analysis, aiding in diagnostic accuracy.
  • The AI-based algorithm in AusculThing ACC effectively detects heart murmurs and categorizes heart sounds as normal or abnormal.
  • The software is designed as a mobile app, making it accessible and user-friendly for healthcare providers.
  • AusculThing Learn is a highly-rated educational tool for learning heart auscultation, featuring real heart sound recordings and anatomical illustrations.
  • The AusculThing Learn app includes a quiz section to challenge users and track skill improvement.
  • The company aims to make cardiopulmonary care more precise, affordable, and adaptable through cutting-edge solutions.

Limitations

  • AusculThing ACC is not intended as a standalone diagnostic device and should be used in conjunction with a physician's expertise and other patient data.
  • No specific company or employer reviews were found on G2, Glassdoor, Capterra, or Reddit.
  • Information regarding pricing for AusculThing ACC is not readily available in the search results.
  • Some general concerns exist about the reliability and potential for bias in reviews on platforms like Capterra and G2.

Based on reviews from: FDA, Vertex AI Search, Apple App Store, Innolitics

Last updated: 2026-10-26

Videos

News, demos, and interviews about AusculThing Oy.

Loading videos...

Videos load interactively. If none appear, search YouTube for AusculThing Oy →

View all on YouTube

Press & Coverage

Medical News Observer
AusculThing ACC Software: A Modern Tool for Heart Sound Analysis
AusculThing Oy's ACC software, an AI-based algorithm, uses an electronic stethoscope to record, display, and analyze heart sounds, aiding healthcare providers in interpreting and evaluating heart sounds in adult and pediatric patients. It boasts an advanced murmur detection feature and categorizes heart sounds as abnormal or normal.
2023-12
FDA
K230823 - 510(k) Premarket Notification - FDA
This is a 510(k) Premarket Notification from AusculThing Oy to the FDA for their device, received on March 24, 2023, and decided as Substantially Equivalent (SESE) on July 12, 2023. The regulation medical specialty is Cardiovascular.
2023-07
Innolitics
AusculThing ACC (K230823) — FDA 510(k) | Innolitics
AusculThing ACC, developed by AusculThing Oy, received FDA clearance through the 510(k) pathway on July 12, 2023, under submission K230823, with the product code DQD.
2023-07
PMC
Automated analysis of heart sound signals in screening for structural heart disease in children - PMC
This peer-reviewed article discusses the automated analysis of heart sound signals using an AI algorithm for screening structural heart disease in children, with several AusculThing Oy shareholders listed as authors. The study found the algorithm had a sensitivity of 69% and specificity of 97% in identifying abnormal heart sounds.
2023-01
AusculThing Oy (Company Website)
AusculThing – Reinventing auscultation
AusculThing Oy aims to redefine cardiopulmonary healthcare with solutions like the FDA-cleared AusculThing ACC Software, which offers detailed heart sound recordings and analyses with high accuracy, sensitivity, and specificity. The company is expanding its research to US hospitals.
unknown
ResearchGate
Age at asthma diagnosis is related to prevalence and characteristics ...
This research output from September 2022 mentions that one of the authors, LL, reports owning stocks of Ausculthing Oy, indicating a connection between the company and medical research.
2022-09
ResearchGate
Valved Holding Chambers in Young Children With Acute Wheezing ...
An article accepted for publication in December 2025 and published online in February 2026, lists Ausculthing Oy under disclosures, suggesting ongoing involvement in medical research.
2026-02
PMC
From theoretical models to practical deployment: A perspective and case study of opportunities and challenges in AI-driven cardiac auscultation research for low-income settings - PMC
This December 2024 article discusses the opportunities and challenges of deploying AI in cardiovascular healthcare, including AI-driven cardiac auscultation research, which is relevant to AusculThing Oy's focus.
2024-12

Frequently Asked Questions

AusculThing Oy offers the AusculThing ACC Software, an FDA-cleared digital solution designed for healthcare professionals to record, display, and analyze heart sounds. It uses an AI-based algorithm, trained on a proprietary database of echocardiogram data, to detect and categorize heart murmurs as normal or abnormal with high accuracy (93% accuracy, 91% sensitivity, 96% specificity). The software is intended to be used with the Thinklabs One electronic stethoscope and functions as a mobile app, providing both acoustic and visual playback of heart sounds to support clinical decisions.
AusculThing Oy's ACC Software is an FDA-cleared medical device, specifically receiving 510(k) premarket notification clearance on July 12, 2023. This indicates that the device has been found substantially equivalent to a legally marketed predicate device, demonstrating its compliance with regulatory standards for safety and effectiveness.
Yes, AusculThing Oy offers 'AusculThing Learn,' an interactive platform designed for medical students and healthcare professionals to enhance their auscultation skills and understanding of phonocardiograms. It provides immersive visual and audio cues, including real heart sound recordings from over 50 pediatric patients with cardiologist-validated diagnoses, and features practice sections and quizzes to sharpen diagnostic abilities.
The specific pricing models or subscription structures for AusculThing Oy's products and services are not publicly detailed in the provided information. However, they offer a 'full solution' which includes a tablet preinstalled with the latest release of ACC software and a Thinklabs One electronic stethoscope.
While detailed information on customer support and technical assistance is not explicitly provided, AusculThing Oy can be contacted via email at [email protected] for inquiries. Their software is designed to be user-friendly as a mobile app, and they offer a quick start or help section within the AusculThing Learn application for users new to auscultation and phonocardiograms.
AusculThing Oy is actively expanding its research to selected hospitals in the US to enable future algorithms for detecting various new heart conditions. While specific partnership names are not extensively detailed, one source mentions industrial partnerships with pharmaceutical companies including Amgen, AstraZeneca, and Boehringer, and an individual owning stocks in AusculThing Oy has received industry-sponsored grants from several pharmaceutical companies.
AusculThing Oy's vision is to redefine cardiopulmonary healthcare with cutting-edge solutions, aiming to make care more precise, affordable, and adaptable, innovating how cardiopulmonary services are structured and delivered from homes to specialized care. They are an FDA-cleared company with a focus on research and development, suggesting a commitment to long-term growth and impact in the digital health market.

Related Companies

Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]

Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]

Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

HeartLung.AI is a health-tech company focused on leveraging artificial intelligence for the early detection and prevention of cardiovascular disease and lung cancer. Their mission is to shift healthcare from late-stage disease treatment to earlier identification and prevention by unlocking clinically actionable information embedded within routine medical imaging. The company has developed several FDA-cleared and breakthrough-designated […]

Heartvue.ai is a healthcare AI company focused on transforming cardiovascular imaging analysis. Founded by a cardiologist with over two decades of experience in advanced cardiac imaging, the company develops AI-powered tools to make advanced cardiac imaging analysis more accessible, consistent, and efficient for healthcare systems. Their mission is to alleviate the burden of manual workflows […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.